Drug Type Small molecule drug |
Synonyms Exodif, Polystyrene sulfonate, Polystyrene sulfonic acid + [9] |
Target |
Mechanism Bacterial toxin inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC8H8O3S |
InChIKeyMAGFQRLKWCCTQJ-UHFFFAOYSA-N |
CAS Registry28210-41-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Clostridium difficile diarrhea | Phase 3 | CA | 01 Mar 2005 | |
Clostridium difficile diarrhea | Phase 3 | CA | 01 Mar 2005 | |
Clostridium difficile diarrhea | Phase 3 | US | 01 Mar 2005 | |
Clostridium difficile diarrhea | Phase 3 | US | 01 Mar 2005 | |
Clostridium difficile diarrhea | Phase 3 | PR | 01 Mar 2005 | |
Clostridium difficile diarrhea | Phase 3 | PR | 01 Mar 2005 | |
Enterocolitis, Pseudomembranous | Phase 3 | US | 01 Mar 2005 | |
Enterocolitis, Pseudomembranous | Phase 3 | CA | 01 Mar 2005 | |
Enterocolitis, Pseudomembranous | Phase 3 | US | 01 Mar 2005 | |
Enterocolitis, Pseudomembranous | Phase 3 | CA | 01 Mar 2005 |
Not Applicable | - | Fecal microbiota transplantation (FMT) after a short course of vancomycin therapy | gfkpyaewcq(hphxbtnyzi) = gnxyutcvfi unqfyzimzv (anuxzxfwlg ) | - | 01 Mar 2021 | ||
emdmszvivt(fivgoxrudk) = ozkuexecva ekbjqyuqrx (kcrgyjmiuu ) |